Hyperphosphatemia is treated by?
**Core Concept**
Hyperphosphatemia refers to an elevated serum phosphate level, which can occur due to various reasons such as kidney dysfunction, excessive phosphate intake, or cellular breakdown. In the context of hyperphosphatemia, the body's primary concern is the precipitation of calcium phosphate in soft tissues, leading to calcification and potential organ damage.
**Why the Correct Answer is Right**
The primary goal of treating hyperphosphatemia is to reduce serum phosphate levels and prevent calcium phosphate deposition. **Phosphate binders** are the cornerstone of treatment, which work by binding to phosphate in the gastrointestinal tract and preventing its absorption. **Calcium carbonate** is a commonly used phosphate binder, which not only reduces phosphate absorption but also helps maintain calcium balance in the body.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while dialysis may be necessary in cases of severe hyperphosphatemia, especially in patients with end-stage renal disease, it is not the primary treatment for hyperphosphatemia.
**Option B:** This option is incorrect because **aluminum-containing phosphate binders** are no longer recommended due to the risk of aluminum toxicity, which can cause neurological and bone disorders.
**Option C:** This option is incorrect because **sodium polystyrene sulfonate** is used to treat hyperkalemia, not hyperphosphatemia.
**Clinical Pearl / High-Yield Fact**
When treating hyperphosphatemia, it is essential to monitor serum calcium levels, as phosphate binders can also affect calcium levels. Additionally, patients with kidney dysfunction may require dialysis or other interventions to manage phosphate levels.
**Correct Answer:** C. Sodium polystyrene sulfonate is not correct, actual correct option was not given